LEVOMEFOLATE MAGNESIUM, LEUCOVORIN, FOLIC ACID, FERROUS CYSTEINE GLYCINATE, MAGNESIUM ASCORBATE, ZINC ASCORBATE, COCARBOXYLASE, FLAVIN ADENINE DINUCLEOTIDE, NADH, PYRIDOXAL PHOSPHATE ANHYDROUS, COBAMAMIDE, BETAINE, MAGNESIUM L-THREONATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, and PHOSPHATIDYL SERINE · LEVOMEFOLATE MAGNESIUM 5.23 mg/1; LEUCOVORIN 2.5 mg/1; FOLIC ACID 1 mg/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; MAGNESIUM ASCORBATE 24 mg/1; ZINC ASCORBATE 1 mg/1; COCARBOXYLASE 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; NADH 25 ug/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; COBAMAMIDE 50 ug/1; BETAINE 500 ug/1; MAGNESIUM L-THREONATE 1 mg/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; PHOSPHATIDYL SERINE 12 mg/1 · Capsule, Delayed Release Pellets · Oral · Jaymac Pharmaceuticals, LLC
NDC 64661-0650-30 · 30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $4.48 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Jaymac Pharmaceuticals, LLC | LEVOMEFOLATE MAGNESIUM 5.23 mg/1; LEUCOVORIN 2.5 mg/1; FOLIC ACID 1 mg/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; MAGNESIUM ASCORBATE 24 mg/1; ZINC ASCORBATE 1 mg/1; COCARBOXYLASE 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; NADH 25 ug/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; COBAMAMIDE 50 ug/1; BETAINE 500 ug/1; MAGNESIUM L-THREONATE 1 mg/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; PHOSPHATIDYL SERINE 12 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Jaymac Pharmaceuticals, LLC | LEVOMEFOLATE MAGNESIUM 6.4 mg/1; LEUCOVORIN 800 ug/1; FOLIC ACID 500 ug/1; FERROUS CYSTEINE GLYCINATE 50 ug/1; MAGNESIUM ASCORBATE 25 ug/1; ZINC ASCORBATE 13.6 mg/1; COCARBOXYLASE 25 ug/1; FLAVIN ADENINE DINUCLEOTIDE 1 mg/1; NADH 2.5 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 5.23 mg/1; COBAMAMIDE 24 mg/1; BETAINE 1 mg/1; MAGNESIUM L-THREONATE 25 ug/1; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 12 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 25 ug/1; PHOSPHATIDYL SERINE 1 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Jaymac Pharmaceuticals, LLC | 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 6.4 mg/1; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM 800 ug/1; BETAINE 500 ug/1; COBAMAMIDE 50 ug/1; COCARBOXYLASE 25 ug/1; FERROUS CYSTEINE GLYCINATE 13.6 mg/1; FLAVIN ADENINE DINUCLEOTIDE 25 ug/1; FOLIC ACID 1 mg/1; LEUCOVORIN 2.5 mg/1; LEVOMEFOLATE MAGNESIUM 5.23 mg/1; MAGNESIUM ASCORBATE 24 mg/1; MAGNESIUM L-THREONATE 1 mg/1; NADH 25 ug/1; PHOSPHATIDYL SERINE 12 mg/1; PYRIDOXAL PHOSPHATE ANHYDROUS 25 ug/1; ZINC ASCORBATE 1 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "EnBrace HR — NDC 64661-0650-30," retrieved September 3, 2026, https://drugdashboards.com/drug/64661065030.
Free to cite with attribution — see how the data is put together.